Alnylam Pharmaceuticals
ALNY
#486
Rank
NZ$85.00 B
Marketcap
NZ$643.42
Share price
-6.87%
Change (1 day)
38.63%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company